Using 1010 matched case-control pairs within the NSHDS, we investigated circulating levels of insulin, C-peptide, adiponectin, and leptin in relation to the risk of CRC, and molecular subtypes of CRC defined by KRAS and BRAF mutation status and MSI status in the tumor. Here, INS is linked to colorectal carcinoma.